本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLine Rx

2.90
+0.08002.84%
盘后2.900.00000.00%16:10 EST
成交量:5,669.00
成交额:1.62万
市值:1,261.89万
市盈率:-2.24
高:2.94
开:2.82
低:2.82
收:2.82
52周最高:7.77
52周最低:2.30
股本:435.14万
流通股本:417.35万
量比:0.44
换手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-1.2972
每股收益(LYR):-4.6176
净资产收益率:-21.24%
总资产收益率:-13.60%
市净率:0.65
市盈率(LYR):-0.63

数据加载中...

2026/01/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/26

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/27

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/09

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/26

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/23

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses